Scott M. Lippman

发表

Selenium effects on prostate cell growth.

A. Sabichi, S. Lippman, D. Menter, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

S. Lippman, J. S. Morris, I. Shureiqi, 2006, Oncogene.

The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival.

I. Wistuba, C. Behrens, L. Solis, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Algorithmic Guided Screening of Drug Combinations of Arbitrary Size for Activity against Cancer Cells

Li Mao, Paul Damien, Elmira Popova, 2022 .

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

O. Harismendy, S. Lippman, E. Szabo, 2018, Clinical Cancer Research.

Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.

Edward S. Kim, S. Lippman, W. Hong, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

A. Garden, S. Lippman, W. Hong, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions.

S. Lippman, F. Khuri, W. Hong, 2000, Seminars in oncology.

Retinoic acid and interferon combination studies in human cancer.

S. Lippman, R. Lotan, W. Hong, 1993, European journal of cancer.

p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas.

S. Lippman, G. Lozano, G. Clayman, 2001, Carcinogenesis.

Evans' syndrome as a presenting manifestation of atypical paroxysmal cold hemoglobinuria.

S. Lippman, F. Grumet, L. Levitt, 1987, The American journal of medicine.

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.

M. Ratain, S. Lippman, R. Stupp, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

C. Etzel, F. Dayyani, Mei Liu, 2010, Head & neck oncology.

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.

S. Lippman, S. Martino, C. Moinpour, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of dasatinib in non-small cell lung cancer (NSCLC).

J. Kurie, Y. Oh, B. Saigal, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma.

R. Collins, A. Sabichi, S. Lippman, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.

S. Lippman, R. Lotan, X. Liu, 1999, Cancer research.

Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.

V. Steele, A. Sabichi, S. Lippman, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic.

R. Lotan, W. Hittelman, W. Ki Hong, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

Edward S. Kim, S. Lippman, F. Khuri, 2009, American journal of clinical oncology.

Edward S. Kim, M. Spitz, S. Lippman, 2010, Carcinogenesis.

Chemoprevention of lung cancer.

S. Lippman, W. Hong, S. Benner, 1995, Chest.

Current status of retinoid chemoprevention of lung cancer.

S. Lippman, W. Hong, S. Benner, 1995, Oncology.

Biomarkers as intermediate end points in chemoprevention trials.

R. Lotan, W. Hong, W. Hittelman, 1990, Journal of the National Cancer Institute.

N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.

S. Lippman, F. Khuri, R. Lotan, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

S. Lippman, R. Perez-soler, F. Fossella, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nivolumab for Patients With High-Risk Oral Leukoplakia

C. Paweletz, L. Alexandrov, R. Uppaluri, 2023, JAMA oncology.